2 Pharmaceutical Stocks Trading Below Their Book Value
Frequently, buying stocks trading below their fundamental net worth can yield lucrative rewards for investors.
Mallinckrodt
MNK
MNK
$2.43
-$0.07
-2.8%
Price as of July 2, 2020, 4:15 p.m. EDT
View Interactive MNK Charts
Mallinckrodt plc Ordinary Shares
Interactive Chart
News & Analysis: Mallinckrodt
The Fool has written over 100 articles on Mallinckrodt.
Top 3 Contrarian Stocks to Buy Right Now
Indiscriminate sell-offs can lead to opportunities the crowds have missed. Here are three stocks that fit the criteria.
Mallinckrodt (MNK) Q1 2020 Earnings Call Transcript
MNK earnings call for the period ending March 31, 2020.
Why Mallinckrodt Stock Tumbled Today
Investors were disappointed by the company's Q1 results and the prospects of continued challenges from the COVID-19 pandemic.
How ANI Pharmaceuticals Plans to Take Down a Price-Gouging Giant
A small-cap pharmaceuticals company may hold the solution to a nearly 100,000% drug price hike.
Mallinckrodt (MNK) Q4 2019 Earnings Call Transcript
MNK earnings call for the period ending December 31, 2019.
Mallinckrodt Reaches Tentative Settlement Deal on Opioid Lawsuits
The $1.6 billion deal would release the pharmaceutical company from all opioid-related claims.
What's Behind Mallinckrodt's Better-Than-Expected Q4 Results
The drugmaker topped Wall Street's estimates for both the top and bottom lines. And it had some other big news that overshadowed its Q4 performance.
Why Mallinckrodt Stock Is Soaring Today
Investors are cheering the company's deal to settle opioid-related lawsuits.
Mallinckrodt Considers Bankruptcy Over Opioid Lawsuits
Shares fell by as much as 45% in light of the news.
